Academic Excellence Paper Presentations

Needs Statement

To address the professional practice gaps in delivering consistent, high-quality, evidence-based care across the Physician Enterprise and CommonSpirit Health, clinicians require targeted education that promotes the consistent application of evidence-based medicine. This includes training that supports the adoption of the CommonSpirit Standard of Care, particularly in clinical areas with high visibility, variation in practice, patient volume, and value. Providers need practical tools and frameworks to interpret and integrate evolving clinical guidelines into their daily workflows, ensuring that new evidence translates into improved patient outcomes. Additionally, education must foster strong interprofessional collaboration by emphasizing shared goals, clear roles, mutual trust, and effective communication among care team members. Recognizing the impact of provider burnout on care quality, educational initiatives should also address workforce well-being by promoting team-based documentation, role optimization, and workflow redesign to reduce administrative burden and enhance job satisfaction.

Educational Objectives

At the conclusion of the activity, the participants should be able to:

• Identify at least three unique barriers or challenges to care reported by Black women with pelvic floor disorders, and describe how these insights can inform ethical, culturally sensitive clinical approaches.
• Explain how the disruption of circadian neural patterns detected via implanted devices serves as a predictive biomarker for clinical response to deep brain stimulation in patients with obsessive-compulsive disorder.
• Evaluate the potential role of sPD-L1 as a prognostic biomarker for mortality in patients with acute respiratory distress syndrome (ARDS) and discuss how targeting PD-L1/PD-1 pathways may offer novel therapeutic strategies for ARDS management.
• Summarize the identified association between clonal hematopoiesis, specifically mutations in the TET2 and ASXL1 genes, and the increased risk or progression of atrial fibrillation (AF) and its implications for understanding AF pathophysiology.
• Recognize the importance of reviewing and discussing new clinical evidence in the context of improving care delivery and patient outcomes.

Target Audience

Activity Evaluation

Evaluation by questionnaire will address program content, presentation, and possible bias.

Educational Methods

• Lectures
• Panel Discussion

Accreditation/Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Baylor College of Medicine and CommonSpirit Health. Baylor College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been designated by Baylor College of Medicine for 1 credit of education in medical ethics and/or professional responsibility.

Term of Approval

December 1, 2025 through December 31, 2027. Original release date: December 1, 2025.

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.